Earnings due 28 Jan 2026: AVE.AX stock Avecho Biotechnology ASX eyes catalyst

The most important near-term event for AVE.AX stock is an earnings update scheduled for 28 Jan 2026. Avecho Biotechnology (AVE.AX) trades at A$0.01 with volume 7,001,923 as traders position ahead of results. With no published EPS and a small market cap of A$29,670,100, the report may move price more than usual for this micro-cap. We examine the numbers, technicals, Meyka AI forecasts and likely catalysts for intraday trading on the ASX.